Nippon India Pharma Fund Direct IDCW
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Direct IDCW
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 01-Jan-2013
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 8264.71
Nippon India Pharma Fund Direct IDCW - Nav Details
Nav Date
: 14-Jan-2026
NAV [Rs.]
: 167.2619
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
:
Exit Load %
:
Nippon India Pharma Fund Direct IDCW- NAV Chart
Nippon India Pharma Fund Direct IDCW- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -2.06 | -0.85 | -0.78 | -1.07 | 2.64 | 22.67 | 15.49 | 17.96 |
| Category Avg | -2.19 | -1.3 | -2.43 | -1.64 | 1.27 | 22.71 | 15.03 | 13.33 |
| Category Best | -0.87 | 0.17 | - | 1.64 | 8.42 | 28.02 | 17.73 | 28.4 |
| Category Worst | -3.69 | -2.56 | -5.99 | -5.48 | -4.74 | 18.12 | 11.33 | -5.75 |
Nippon India Pharma Fund Direct IDCW- Latest Dividends
Record DateDividend %Bonus
21-Feb-20241000
Nippon India Pharma Fund Direct IDCW- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 13.02 | 6256349 | 1,075.90 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 7.36 | 2883991 | 608.37 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 6.58 | 850754 | 543.84 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 6.39 | 3495054 | 528.20 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 6.02 | 3916074 | 497.88 |
| Equity | Apollo Hospitals | Healthcare Services | 5.53 | 648795 | 456.91 |
| Equity | Vijaya Diagnost. | Healthcare Services | 3.71 | 2886684 | 306.27 |
| Equity | Medplus Health | Retailing | 3.54 | 3627277 | 292.83 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 3.21 | 959323 | 265.62 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 2.81 | 2555745 | 232.16 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 2.73 | 913226 | 225.89 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.61 | 74187 | 215.32 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.44 | 1702630 | 201.42 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.37 | 4392120 | 195.75 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 2.20 | 999649 | 181.90 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.19 | 1218224 | 180.61 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.16 | 323678 | 178.23 |
| Equity | Narayana Hrudaya | Healthcare Services | 2.12 | 923911 | 174.80 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.05 | 1194164 | 169.43 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.01 | 757496 | 166.38 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.92 | 318249 | 158.73 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.67 | 800549 | 137.85 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.27 | 3896349 | 105.06 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 1.23 | 746337 | 101.83 |
| Equity | Fortis Health. | Healthcare Services | 1.18 | 1103889 | 97.58 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.17 | 213659 | 96.57 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 1.14 | 230272 | 94.11 |
| Equity | Max Healthcare | Healthcare Services | 1.13 | 891340 | 93.15 |
| Equity | Syngene Intl. | Healthcare Services | 1.09 | 1380492 | 89.87 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.06 | 2219374 | 87.42 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 0.83 | 1058503 | 68.96 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 0.83 | 1515264 | 68.70 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.68 | 62568 | 56.49 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.52 | 1834924 | 43.04 |
| Equity | Orchid Pharma | Pharmaceuticals & Biotechnology | 0.42 | 457561 | 34.72 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.18 | 111738 | 15.03 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,11,597.56
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
